143 related articles for article (PubMed ID: 34479374)
1. Early response evaluation using 18F-FDG-PET/CT does not influence management of patients with metastatic gastrointestinal stromal tumors (GIST) treated with palliative intent.
Farag S; IJzerman NS; Houdijk MPM; Reyners AKL; Arens AI; Grünhagen DJ; Desar IME; Gelderblom H; Steeghs N; de Geus-Oei LF
Nuklearmedizin; 2021 Dec; 60(6):411-416. PubMed ID: 34479374
[TBL] [Abstract][Full Text] [Related]
2. Early Evaluation of Response Using
Farag S; Geus-Oei LF; van der Graaf WT; van Coevorden F; Grunhagen D; Reyners AKL; Boonstra PA; Desar I; Gelderblom H; Steeghs N
J Nucl Med; 2018 Feb; 59(2):194-196. PubMed ID: 28970330
[No Abstract] [Full Text] [Related]
3. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
Gayed I; Vu T; Iyer R; Johnson M; Macapinlac H; Swanston N; Podoloff D
J Nucl Med; 2004 Jan; 45(1):17-21. PubMed ID: 14734662
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
[TBL] [Abstract][Full Text] [Related]
5. The value of (18) F-fluorodeoxyglucose positron emission tomography for prediction of treatment response in gastrointestinal stromal tumors: a systematic review and meta-analysis.
Hassanzadeh-Rad A; Yousefifard M; Katal S; Asady H; Fard-Esfahani A; Moghadas Jafari A; Hosseini M
J Gastroenterol Hepatol; 2016 May; 31(5):929-35. PubMed ID: 26642423
[TBL] [Abstract][Full Text] [Related]
6. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Kim SJ; Lee SW
J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
[TBL] [Abstract][Full Text] [Related]
7. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
8. Patterns of extension of gastrointestinal stromal tumors (GIST) treated with imatinib (Gleevec®) by 18F-FDG PET/CT.
Valls-Ferrusola E; García-Garzón JR; Ponce-López A; Soler-Peter M; Fuertes-Cabero S; Moragas-Solanes M; Riera-Gil E; Carrió-Gasset I; Lomeña-Caballero F
Rev Esp Enferm Dig; 2012 Jul; 104(7):360-6. PubMed ID: 22849497
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Montemurro M; Cioffi A; Dômont J; Rutkowski P; Roth AD; von Moos R; Inauen R; Toulmonde M; Burkhard RO; Knuesli C; Bauer S; Cassier P; Schwarb H; Le Cesne A; Koeberle D; Bärtschi D; Dietrich D; Biaggi C; Prior J; Leyvraz S
Cancer; 2018 Apr; 124(7):1449-1454. PubMed ID: 29315500
[TBL] [Abstract][Full Text] [Related]
11. Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to
Van Weehaeghe D; Gheysens O; Vandecaveye V; Schöffski P; Van Laere K; Deroose CM
BMC Cancer; 2018 Mar; 18(1):253. PubMed ID: 29506493
[TBL] [Abstract][Full Text] [Related]
12.
Altini C; Mammucci P; Pisani AR; D'Alò C; Sardaro A; Rubini D; Ferrari C; Rubini G
Hell J Nucl Med; 2021; 24(3):239-246. PubMed ID: 34901964
[TBL] [Abstract][Full Text] [Related]
13. Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors.
Revheim ME; Hole KH; Mo T; Bruland ØS; Reitan E; Julsrud L; Seierstad T
Acta Radiol; 2022 Aug; 63(8):995-1004. PubMed ID: 34171968
[TBL] [Abstract][Full Text] [Related]
14. Role of 18F-FDG PET/CT in restaging and follow-up of patients with GIST.
Albano D; Mattia B; Giubbini R; Bertagna F
Abdom Radiol (NY); 2020 Mar; 45(3):644-651. PubMed ID: 31646354
[TBL] [Abstract][Full Text] [Related]
15. Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT Criteria.
Meyer M; Hohenberger P; Overhoff D; Bartsch A; Henzler T; Haubenreisser H; Ronald J; Schmidt B; Flohr T; Sedlmair M; Ota H; Messiou C; Schoenberg SO; Riedel RF; Nelson RC; Marin D
AJR Am J Roentgenol; 2022 Apr; 218(4):659-669. PubMed ID: 34668385
[No Abstract] [Full Text] [Related]
16. Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist.
Albano D; Bosio G; Tomasini D; Bonù M; Giubbini R; Bertagna F
Asia Pac J Clin Oncol; 2020 Oct; 16(5):e207-e215. PubMed ID: 32762133
[TBL] [Abstract][Full Text] [Related]
17. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
Heinicke T; Wardelmann E; Sauerbruch T; Tschampa HJ; Glasmacher A; Palmedo H
Anticancer Res; 2005; 25(6C):4591-4. PubMed ID: 16334147
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of preoperative
Miyake KK; Nakamoto Y; Mikami Y; Tanaka S; Higashi T; Tadamura E; Saga T; Minami S; Togashi K
Eur Radiol; 2016 Dec; 26(12):4664-4674. PubMed ID: 26852217
[TBL] [Abstract][Full Text] [Related]
19. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
20. [Early response to treatment with Glivec detected with 18F-FDG PET in a patient with gastrointestinal stromal tumor].
Delgado Bolton RC; Ortega Candil A; Pérez Castejón MJ; Garcerant M; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2008; 27(2):112-7. PubMed ID: 18367049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
